4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The primary purpose of the study is to determine the safety and tolerability of AZD1446 vs Placebo given as an add-on treatment to Donepezil for 4 weeks in patients with mild to moderate Alzheimer\'s disease.
Epistemonikos ID: 0ad9760cc59ebdd1d07c964ba78cec62c567afbc
First added on: May 05, 2024